Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-359675

Co-Chief Executive Officer acquired 60,039 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Joshua B Co-Chief Executive Officer 2026-08-18 Grant or award +60,039 3,643,587 D
Loading xslF345X06/ownership.xml…